APA

Tsimafeyeu I., Khasanova A., Stepanova E., Gordiev M., Khochenkov D., Naumova A., Varlamov I., Snegovoy A. & Demidov L. (20170214). FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Tsimafeyeu I, Khasanova A, Stepanova E, Gordiev M, Khochenkov D, Naumova A, Varlamov I, Snegovoy A and Demidov L. 20170214. FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Tsimafeyeu I., Khasanova A., Stepanova E., Gordiev M., Khochenkov D., Naumova A., Varlamov I., Snegovoy A. and Demidov L. (20170214). FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Tsimafeyeu I, Khasanova A, Stepanova E, Gordiev M, Khochenkov D, Naumova A, Varlamov I, Snegovoy A and Demidov L. FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20170214.